News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
725,613 Results
Type
Article (43959)
Company Profile (312)
Press Release (681342)
Section
Business (212004)
Career Advice (2125)
Deals (36430)
Drug Delivery (99)
Drug Development (82297)
Employer Resources (178)
FDA (16718)
Job Trends (15350)
News (356339)
Policy (33411)
Tag
2024 BioCapital Digital (7)
2024 BioForest Digital (7)
2024 BioForest Standard (1)
2024 BioMidwest Digital (8)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (7)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (19)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (6)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (7)
2024 Pharm Country Digital (7)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2705)
Accelerated approval (4)
Adcomms (20)
Allergies (84)
Alliances (52472)
ALS (84)
Alzheimer's disease (1382)
Antibody-drug conjugate (ADC) (120)
Approvals (16716)
Artificial intelligence (263)
Autoimmune disease (16)
Automation (14)
Bankruptcy (365)
Best Places to Work (11964)
BIOSECURE Act (18)
Biosimilars (102)
Biotechnology (221)
Bladder cancer (60)
Brain cancer (25)
Breast cancer (254)
Cancer (2045)
Cardiovascular disease (163)
Career advice (1779)
Career pathing (31)
CAR-T (148)
Cell therapy (415)
Cervical cancer (19)
Clinical research (66554)
Collaboration (809)
Compensation (470)
Complete response letters (19)
COVID-19 (2671)
CRISPR (40)
C-suite (221)
Cystic fibrosis (102)
Data (2002)
Decentralized trials (2)
Denatured (28)
Depression (40)
Diabetes (251)
Diagnostics (6608)
Digital health (18)
Diversity (9)
Diversity, equity & inclusion (44)
Drug discovery (117)
Drug pricing (98)
Drug shortages (27)
Duchenne muscular dystrophy (86)
Earnings (87862)
Editorial (32)
Employer branding (22)
Employer resources (153)
Events (116477)
Executive appointments (675)
FDA (17861)
Featured Employer (51)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (723)
Gene editing (105)
Generative AI (25)
Gene therapy (295)
GLP-1 (705)
Government (4489)
Grass and pollen (5)
Guidances (49)
Healthcare (19569)
Huntington's disease (23)
IgA nephropathy (26)
Immunology and inflammation (105)
Indications (27)
Infectious disease (2806)
Inflammatory bowel disease (136)
Inflation Reduction Act (8)
Influenza (49)
Intellectual property (90)
Interviews (330)
IPO (16832)
IRA (41)
Job creations (3825)
Job search strategy (1516)
Kidney cancer (9)
Labor market (34)
Layoffs (471)
Leadership (16)
Legal (8125)
Liver cancer (72)
Lung cancer (297)
Lymphoma (136)
Machine learning (4)
Management (63)
Manufacturing (277)
MASH (62)
Medical device (14071)
Medtech (14076)
Mergers & acquisitions (20089)
Metabolic disorders (642)
Multiple sclerosis (73)
NASH (16)
Neurodegenerative disease (84)
Neuropsychiatric disorders (24)
Neuroscience (1875)
NextGen: Class of 2025 (6862)
Non-profit (4628)
Northern California (2474)
Now hiring (37)
Obesity (343)
Opinion (217)
Ovarian cancer (72)
Pain (79)
Pancreatic cancer (77)
Parkinson's disease (138)
Partnered (20)
Patents (213)
Patient recruitment (97)
Peanut (49)
People (59414)
Pharmaceutical (69)
Pharmacy benefit managers (18)
Phase I (20877)
Phase II (29284)
Phase III (21745)
Pipeline (1060)
Podcasts (71)
Policy (116)
Postmarket research (2584)
Preclinical (8913)
Press Release (71)
Prostate cancer (94)
Psychedelics (30)
Radiopharmaceuticals (263)
Rare diseases (366)
Real estate (6234)
Recruiting (66)
Regulatory (22756)
Reports (46)
Research institute (2462)
Resumes & cover letters (363)
Rett syndrome (4)
RNA editing (4)
RSV (41)
Schizophrenia (66)
Series A (128)
Series B (80)
Service/supplier (15)
Sickle cell disease (52)
Southern California (2152)
Special edition (14)
Spinal muscular atrophy (148)
Sponsored (29)
Startups (3841)
State (2)
Stomach cancer (13)
Supply chain (61)
Tariffs (11)
The Weekly (41)
United States (21846)
Vaccines (691)
Venture capitalists (38)
Webinars (13)
Weight loss (230)
Women's health (34)
Worklife (16)
Date
Today (109)
Last 7 days (746)
Last 30 days (2761)
Last 365 days (34447)
2025 (8437)
2024 (36260)
2023 (41161)
2022 (52428)
2021 (57032)
2020 (55661)
2019 (48516)
2018 (36502)
2017 (33570)
2016 (33179)
2015 (39385)
2014 (32958)
2013 (28005)
2012 (30258)
2011 (30871)
2010 (28823)
Location
Africa (761)
Alabama (50)
Alaska (7)
Arizona (233)
Arkansas (14)
Asia (40407)
Australia (6728)
California (5672)
Canada (1890)
China (486)
Colorado (254)
Connecticut (266)
Delaware (135)
Europe (88408)
Florida (833)
Georgia (206)
Idaho (60)
Illinois (524)
India (24)
Indiana (299)
Iowa (9)
Japan (144)
Kansas (103)
Kentucky (24)
Louisiana (9)
Maine (61)
Maryland (847)
Massachusetts (4327)
Michigan (229)
Minnesota (381)
Mississippi (2)
Missouri (83)
Montana (30)
Nebraska (25)
Nevada (57)
New Hampshire (68)
New Jersey (1623)
New Mexico (28)
New York (1627)
North Carolina (971)
North Dakota (8)
Northern California (2474)
Ohio (198)
Oklahoma (15)
Oregon (36)
Pennsylvania (1278)
Puerto Rico (10)
Rhode Island (27)
South America (1156)
South Carolina (18)
South Dakota (1)
Southern California (2152)
Tennessee (97)
Texas (846)
Utah (171)
Virginia (134)
Washington D.C. (58)
Washington State (530)
West Virginia (3)
Wisconsin (51)
725,613 Results for "align technology inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
JenaValve Announces Late-Breaking Data from the ALIGN-AR Pivotal Trial
April 1, 2025
·
3 min read
Press Releases
Ocugen, Inc. Announces FDA Alignment on Phase 2/3 Pivotal Confirmatory Clinical Trial for Modifier Gene Therapy Candidate OCU410ST for Stargardt Disease
February 27, 2025
·
6 min read
Press Releases
SynOx Therapeutics Announces Board Chair Transition to Align with Advancing Regulatory and Commercialization Strategy
April 2, 2025
·
4 min read
Business
Align Technology Appoints Emory Wright, EVP Direct Fabrication Manufacturing Platform to Build the Company’s Next Generation Manufacturing Operations -- Wright Plans to Retire in 2026
Align Technology, Inc. today announced it has appointed Emory Wright, executive vice president, direct fabrication manufacturing platform, effective immediately.
May 22, 2024
·
5 min read
Business
Align Technology Announces Fourth Quarter and Fiscal 2023 Financial Results
Align Technology, Inc., a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, reported financial results for the fourth quarter and year ended December 31, 2023.
January 31, 2024
·
35 min read
BioMidwest
Align Technology Announces $100 Million Open Market Repurchase
Align Technology, Inc. announced that it is planning to repurchase $100 million of Align’s common stock through open market repurchases under Align’s $1.0 billion stock repurchase program that was approved by Align’s Board of Directors in January 2023.
November 6, 2023
·
4 min read
C-suite
GSK CEO Emma Walmsley Gets Pay Bump To Align With Pharma Peers
One of the lowest paid CEOs in pharma—and one of the only woman leading a top-tier giant—is set to receive up to $27.2 million in 2025.
February 27, 2025
·
2 min read
·
Annalee Armstrong
Press Releases
Genelux Announces Alignment with FDA on Key Elements of the Approval Pathway for Olvi-Vec in Platinum Resistant/Refractory Disease
March 26, 2025
·
6 min read
Genetown
Checkpoint Therapeutics Announces Alignment with FDA Enabling Upcoming Cosibelimab BLA Resubmission
Checkpoint Therapeutics, Inc. today announced it has reached alignment with the Food and Drug Administration (“FDA”) on its biologics license application (“BLA”) resubmission strategy for cosibelimab.
June 24, 2024
·
5 min read
Press Releases
Castle Biosciences to Present New Data at EADO Supporting the Clinical Value of the DecisionDx®-Melanoma Test in Guiding Risk-Aligned Management of Patients with Melanoma
April 1, 2025
·
7 min read
1 of 72,562
Next
